International Clinical Trial: Optimization of Dosing Regimens and Mechanistic Exploration of Novel Tetracyclines in Patients with Drug-Resistant Bacterial Infections

Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126465) titled 'Optimization of Dosing Regimens and Mechanistic Exploration of Novel Tetracyclines in Patients with Drug-Resistant Bacterial Infections' on June 9.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: The First Affiliated Hospital of Xi'an Jiaotong University

Condition: Respiratory tract infection, Skin and soft tissue infection (SSTI), Bloodstream infection (BSI), Intra-abdominal infection (IAI), Urinary tract infection (UTI)

Intervention: Eravacycline arm:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-06-09

Target Sample Size: Eravacycline ...